Corporate brand campaign launched in India by Sun Pharma

Sun Pharmaceutical Industries Limited (Sun Pharma), India's largest pharmaceutical company, has initiated a brand campaign that celebrates its contribution to the lives of people. Called 'touching 1,000...

Pharma Quality Excellence Awards 2025 - Celebration and Conclusion

The Pharma Quality Excellence Awards 2025 ceremony marked a significant milestone in recognizing outstanding contributions to pharmaceutical quality standards. Held in Hotel Westin Mumbai Garden City, it brought together industry leaders, quality pro

Pharma Science Revives Ayurveda with Zero Investment Plan

Pharma Science, a leader in India's Ayurvedic healthcare industry, is revolutionizing natural wellness with clinically proven, patented products and an open business model...

Venus Remedies Taps Ekta S. Chaudhary to Lead Venus Foundation

Venus Remedies has declared the appointment of Ekta S. Chaudhary as the new Chairperson of the Venus Foundation, marking a major step in the company’s commitment to social responsibility.

ProBioGen & Polpharma Biologics team up for biosimilar cell lines

Cell line development expert ProBioGen has declared the partnership with biotech firm Polpharma Biologics to deliver cell line for one of the biosimilar molecules being developed by Polpharma...

Indian Drugmakers Face Heat as FDA Expands Surprise Global Inspections

In an effort to improve consumer safety and reinforce regulatory compliance, the US Food and Drug Administration (FDA) announced on Tuesday that it will raise the frequency of surprise inspections at foreign manufacturing facilities.

DTAB Recommends All Antimicrobials Be Treated as New Drugs to Tackle AMR

In a major regulatory move aimed at curbing antimicrobial resistance (AMR), the Drugs Technical Advisory Board (DTAB) has recommended that all antimicrobials should be permanently classified as...

Lupin Launches Eslicarbazepine Acetate in U.S. with 180-Day Exclusivity

Global pharmaceutical company Lupin Limited has announced the launch of Eslicarbazepine Acetate Tablets in the U.S. market, following the approval of its Abbreviated New Drug Application (ANDA) by the U...

Alembic Pharma Eyes FY26 Growth with Domestic Surge and Global Push

Alembic Pharmaceuticals has raised its expectation margin for FY26, with increased domestic sales, and international expansion. The CFO of the company, R.K.Baheti informed Moneycontrol that the company recorded higher E...

Indian Pharma Faces US Setback Amid Push for Domestic Drug Manufacturing

Indian pharmaceutical companies may encounter significant hurdles in the US following President Donald Trump’s new executive orders aimed at promoting domestic drug production...

© 2025 India Pharma Outlook. All Rights Reserved.